Figures computed from official regulatory filings — .
Ownershipinsiders 0.11% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for MYMETICS CORP only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
1 buy2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| KEMPERS Ronald Hugo Gerard | AwardD (derivative) | $100K | SEC |
| Fleury Sylvain | AwardD (derivative) | $16K | SEC |
| Fleury Sylvain | AwardD (derivative) | $49K | SEC |
| KEMPERS Ronald Hugo Gerard | OtherD (derivative) | $60K | SEC |
| KEMPERS Ronald Hugo Gerard | Exercise | $60K | SEC |
| Martin Jacques Francois | AwardD (derivative) | $70K | SEC |
| Martin Jacques Francois | Sell | $30K | SEC |
| ROCHET CHRISTIAN | Sell | $325.9K | SEC |
| Stern Ernest M | Award | n/a (No price was disclosed in the filing) | SEC |
| Stern Ernest M | Award | n/a (No price was disclosed in the filing) | SEC |
| LUEBKE ERNST | Award | $2.5M | SEC |
| LUEBKE ERNST | Award | n/a (No price was disclosed in the filing) | SEC |
| ROCHET CHRISTIAN | Buy | n/a (No price was disclosed in the filing) | conv 70First in 12mo | SEC |
| KHD HUMBOLDT WEDAG INTERNATIONAL LTD. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KHD HUMBOLDT WEDAG INTERNATIONAL LTD. | Other | n/a (No price was disclosed in the filing) | SEC |
| KHD HUMBOLDT WEDAG INTERNATIONAL LTD. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |